Holding place for old articles.
Montgomery County has a plan to market itself as a business and tourist destination to a particularly captive audience — one traveling at 30,000 feet.
During April, air travelers on some 1,700 U.S. Airways flights, and select American Airlines flights (for business first class travelers only), will be targeted with videos promoting Montgomery County as a place to relocate a business, to live, work and play.
Demonstrating its deep interest in the future of rare diseases, Pfizer ($PFE) has signed on to partner with Gaithersburg, MD-based GlycoMimetics on its lead drug program for sickle cell disease, promising up to $340 million in a broad array of milestones and an unspecified upfront payment. The partnership will bring in Pfizer on the development of GMI-1070, an inflammation inhibitor that researchers have been studying in a Phase II trial for the painful vaso-occlusive crises that threaten the organs of sickle cell patients.
Wednesday, March 20, 2013, 04:30pm – 07:30pm
Join us on March 20 at Growlers for another BioBuzz Happy Hour
Join our sponsors, BioHealth Innovation, Inc. (BHI) and the Johns Hopkins University Center for Biotechnology Education, along with many others from our local biotech industry at another exciting BioBuzz event on March 20 from 4:30 – 7 p.m. in Gaithersburg. This month, we’re having our event a week early to accommodate BioBuzzers with kids in Montgomery County Public School system who will be on spring break the next week. We’re also holding the March BioBuzz event at a new location, Growlers in Old Towne Gaithersburg. We’re excited to see all of you soon, so please register today!
As part of the Wyle-led team, Lockheed Martin [NYSE: LMT] has been selected by NASA’s Johnson Space Center to provide biomedical, medical and health services in support of all human spaceflight programs. These services under the Human Health and Performance Contract (HHPC) monitor astronaut health and enable bioastronautics research that benefits life on Earth.
The potential contract value to Lockheed Martin is about $250 million over the expected 10-year life of the contract. Lockheed Martin is responsible for flight hardware development, facilitation of life sciences research conducted on the International Space Station (ISS), human factors engineering to optimize tools and experiments for astronauts in zero gravity, radiation analysis, space food development, flight/ground crew training, and life sciences data archival.
MedImmune’s Gaithersburg headquarters will gain 300 new jobs under a broader U.S. consolidation by parent company AstraZeneca PLC, the companies announced Monday.
The move follows management changes at both companies. Pascal Soriot was named AstraZeneca CEO in August, and early this year carried out a leadership shuffle that included installing Bahija Jallal as MedImmune’s new chief. She replaces Peter Greenleaf, who is heading AZ’s Latin American unit.
Roughly three years after announcing that he was expanding his California bioscience incubator to San Antonio, InCube Labs founder Mir Imran may wish he had made the move even sooner.
InCube has found willing investors, as well as corporate and community support, in the nation’s seventh largest city. That has allowed the organization to adjust its expectations and strategies in a way that could prove to be hugely beneficial for the life sciences entity and for San Antonio long-term.
In laboratory studies, Johns Hopkins researchers say they have found that stem cells from a patient’s own fat may have the potential to deliver new treatments directly into the brain after the surgical removal of a glioblastoma, the most common and aggressive form of brain tumor.
The investigators say so-called mesenchymal stem cells (MSCs) have an unexplained ability to seek out damaged cells, such as those involved in cancer, and may provide clinicians a new tool for accessing difficult-to-reach parts of the brain where cancer cells can hide and proliferate anew. The researchers say harvesting MSCs from fat is less invasive and less expensive than getting them from bone marrow, a more commonly studied method.
Results of the Johns Hopkins proof-of-principle study are described online in the journal PLOS ONE.
Every week we give you a countdown of the top five to 10 companies or organizations from one of our Lists publishing in our Friday paper. This week I present to you the top five “Venture capital firms investing the most in Maryland companies,” ranked by total amount invested in Maryland companies in 2012. This information was provided to us by the folks at MoneyTree Report by PricewaterhouseCoopers and the National Venture Capital Association based on data from Thomson Reuters.
Known for its ancient castles and seaside mosques, the Turkish city of Trabzon is looking to raise its profile on a new front—biotechnology.
For inspiration on expanding the Trapzon region’s high-tech and environmental-based industry, a foreign delegation arrived in Baltimore on Tuesday to meet with the Maryland Department of Business & Economic Development.
